Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
13 studies found for:    Klippel-Trenaunay Syndrome (KTS)

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome
Condition: Sturge-Weber Syndrome
Intervention: Drug: Cannabidiol
2 Recruiting Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome
Condition: Sturge-Weber Syndrome
Intervention:
3 Recruiting Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)
Condition: Sturge Weber Syndrome
Intervention: Drug: Everolimus
4 Completed Use of the Atkins Diet for Children With Sturge Weber Syndrome
Conditions: Epilepsy;   Sturge Weber Syndrome
Intervention: Dietary Supplement: modified Atkins diet
5 Recruiting Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol
Conditions: Sturge Weber Syndrome;   Port-wine Mark
Interventions: Drug: Timolol;   Drug: Preservative free artificial tear gel.
6 Completed Incidence of Ocular Antibodies in Patients With Sturge - Weber Syndrome (SWS)
Condition: Sturge - Weber Syndrome (SWS)
Intervention:
7 Completed Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber Syndrome
Condition: Sturge- Weber Syndrome
Intervention: Drug: Drug: Topical Rapamycin
8 Completed Biomarker Development in Sturge-Weber Syndrome
Condition: Sturge-Weber Syndrome
Intervention:
9 Active, not recruiting French National Cohort of Children With Port Wine Stain
Conditions: Port Wine Stain;   Klippel Trenaunay Syndrome;   Parkes Weber Syndrome
Intervention: Genetic: search for polymorphisms of RASA1 gene
10 Completed Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia
Interventions: Drug: Tranexamic acid first, than placebo;   Drug: First placebo, than Tranexamic acid.
11 Recruiting Institutional Registry of Haemorrhagic Hereditary Telangiectasia
Condition: Haemorrhagic Hereditary Telangiectasia
Intervention:
12 Unknown † Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Intervention: Drug: Thalidomide
13 Completed Positive Exposure: A Photography and Video Intervention for Individuals With Craniofacial Differences
Condition: Craniofacial Differences
Intervention:
To Top

† Indicates status has not been verified in more than two years